Sentences with word «onchocerciasis»

Use of this technology to exclude patients from ivermectin - based treatment at the point of care in Loa - endemic regions would allow resumption / expansion of mass drug administration programs for onchocerciasis and lymphatic filariasis in Central Africa.

The illness, scientifically known as onchocerciasis, is caused by the parasitic worm Onchocerca volvulus.

Efforts to eliminate onchocerciasis and lymphatic filariasis in Central Africa through mass drug administration have been suspended because of ivermectin - associated serious adverse events, including death, in patients infected with the filarial parasite Loa loa.

To safely administer ivermectin for onchocerciasis or lymphatic filariasis in regions co-endemic with L. loa, a strategy termed «test and (not) treat» has been proposed whereby those with high levels of L. loa microfilariae (> 30,000 / ml) that put them at risk for life - threatening serious adverse events are identified and excluded from mass drug administration.

KENILWORTH, N.J. --(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell, a retired scientist from Merck Research Laboratories, who was jointly named the 2015 Nobel Prize winner in Physiology or Medicine with Satoshi Omura for the discovery of avermectin, which led to Merck's development of Mectizan (ivermectin), a treatment for river blindness (also known as onchocerciasis) in Africa, Latin America and Yemen.

Onchocerca volvulus population biology and the molecular pathogenesis of onchocerciasis (river blindness)

While medications currently exist to treat lymphatic filariasis and onchocerciasis, the two main diseases caused by filarial nematodes, the drugs are insufficient to eliminate the diseases by 2020 and researchers project that resistance will arise to some of the drugs.

The researchers» approach «to identify biomarkers is certainly elegant and innovative,» writes Michel Boussinesq, an onchocerciasis expert at the Institute of Research for Development in Montpellier, France, in an e-mail.

A major challenge facing mass drug administration (MDA) programmes targeting the control and elimination of lymphatic filariasis or onchocerciasis

Those individuals with high levels of co-infection are the most likely to experience adverse reactions to ivermectin, the deworming drug used to target lymphatic filariasis and onchocerciasis.

The Tool can visualize the geographical distribution of all of the main preventative chemotherapy (PCT) NTDs: schistosomiasis, soil - transmitted helminths, lymphatic filariasis, onchocerciasis and blinding trachoma.

A major challenge facing mass drug administration (MDA) programmes targeting the control and elimination of lymphatic filariasis or onchocerciasis is the serious adverse - sometimes life threatening - reactions that this treatment can have on people who are also infected with loisasis.

River blindness, or onchocerciasis, is a disease caused by a parasitic worm found primarily in Africa.

Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community - directed treatment with ivermectin: a cross-sectional study and comparison over 28 years